Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Gland Pharma LimitedGland Pharma Limited
VS
Fresenius KabiFresenius Kabi
Gland Pharma Limited

Gland Pharma Limited

Sy. No: 143 to 148/150&151, DP Pally Near Gandimaisamma X Road, Hyderabad, Telangana, 500 043, IN

Last Update: 11/12/2025

View Profile
Between 750 and 799
http://www.glandpharma.com
765/1000Fair

Established in Hyderabad, India in 1978, Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the re...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:3,537
Subsidiaries:32
12-month incidents
0
Known data breaches
0
Attack type number
0
Fresenius Kabi

Fresenius Kabi

Else-Kröner-Straße 1, Bad Homburg, Hessen, DE, 61352

Last Update: 11/09/2026

View Profile
792/1000Fair

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:25,877
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Gland Pharma Limited

Gland Pharma Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Fresenius Kabi

Fresenius Kabi

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Gland Pharma Limited in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi in 2026.

Incidents

Incident History - Gland Pharma Limited (X = Date, Y = Severity)

Gland Pharma Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Fresenius Kabi (X = Date, Y = Severity)

Fresenius Kabi cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Gland Pharma Limited

Gland Pharma Limited

Incidents
No explicit notable incidents reported.
Fresenius Kabi

Fresenius Kabi

Incidents
No explicit notable incidents reported.

FAQ

Between Gland Pharma Limited company and Fresenius Kabi company, which one has the best AI Cybersecurity Score ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one has experienced more cyber incidents in the past ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one has experienced more cyber incidents this year ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one has experienced at least one ransomware attack ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one has experienced at least one data breach ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one has experienced at least one targeted cyberattack ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one has experienced at least one vulnerability ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one holds the most compliance certifications ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one holds the fewest compliance certifications ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one has the most subsidiaries ?
Between Gland Pharma Limited company and Fresenius Kabi company, which one has the largest number of employees ?
Between Gland Pharma Limited and Fresenius Kabi, which company holds both SOC 2 Type 1 certifications ?
Between Gland Pharma Limited and Fresenius Kabi, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Gland Pharma Limited or Fresenius Kabi ?
Which company is PCI DSS compliant - Gland Pharma Limited or Fresenius Kabi ?
Between Gland Pharma Limited and Fresenius Kabi, which company complies with HIPAA regulations for healthcare data ?
Between Gland Pharma Limited and Fresenius Kabi, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-94426
SUMMARY

A vulnerability was determined in xuxueli xxl-job up to 3.5.0. The impacted element is an unknown function of the file /jobgroup/insert. This manipulation of the argument Name causes cross site scripting. The attack can be initiated remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 3.5)
CVSS2
Base Score: 4.0
Complexity: LOW
AV:N/AC:L/Au:S/C:N/I:P/A:N
CVSS3
Base Score: 3.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
CVSS4
Base Score: 2.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.1
CVE-2026-94425
SUMMARY

A vulnerability was found in Moore Threads MTT S80 Driver Package 340.150. The affected element is the function sub_140006F0C in the library mtdispkm64.sys of the component IOCTL Handler. The manipulation results in improper privilege management. Attacking locally is a requirement. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 8.8)
CVSS2
Base Score: 6.8
Complexity: LOW
AV:L/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
2
CVE-2026-94627
SUMMARY

vLLM Mooncake connector through 0.29.0 fails to properly manage GPU KV cache block ownership when concurrent child requests share a single transfer ID in prefill/decode disaggregated deployments. Attackers can trigger GPU memory exhaustion by submitting completion requests with multiple prompts, causing orphaned KV cache blocks to accumulate until process restart and eventually preventing legitimate requests from executing.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-94626
SUMMARY

vLLM through 0.29.0 fails to validate the tp_size parameter in kv_transfer_params on OpenAI-compatible completion endpoints, allowing attackers to allocate unbounded memory. Attackers can supply arbitrary tp_size values in prefill/decode disaggregated deployments to exhaust memory and trigger kernel OOM-kill of the decode worker process.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-94625
SUMMARY

vLLM through 0.29.0 contains a resource exhaustion vulnerability in MooncakeConnector where rejected prefill requests create ownerless transfer placeholders that are never reclaimed. Attackers can send rejected requests to exhaust sender task pools, causing valid requests to be delayed by up to 480 seconds while health checks continue returning success.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9